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Mycotic aneurysm of the aorta is an uncommon condition, and Group B Streptococcus
(GBS†) is exceedingly rare in this setting. We present the first reported case of a GBS-in-
fected abdominal aortic aneurysm (AAA) in North America. Key clinical and imaging findings
and pathologic correlation are highlighted. A relevant review of the literature is discussed,
which will bring the reader up to date with this specific disease entity.
introduction
Focal dilatation of any artery is termed
as an aneurysm. The most common site for
an arterial aneurysm is the abdominal aorta,
and a diameter of more than 3 cm is gener-
ally considered as aneurysmal [1]. The in-
cidence of AAA has been increasing [2].
This has been attributed in part to increased
use of ultrasonography and other cross-sec-
tional imaging (computed tomography and
magnetic resonance imaging of abdomen),
resulting in increased incidental case find-
ing. AAA greater than 4 cm in diameter is
considered  clinically  important,  and  its
prevalence was found to be 1.4 percent be-
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aneurysm, abdominal aortic aneurysm, antimicrobial therapytween the ages of 50 to 79 in a study per-
formed in the United States [3]. Another
study performed in Europe estimated the
prevalence of AAA greater than 4 cm to be
about 1 percent in men between the ages of
55 and 64 [4]. The incidence of ruptured
AAA is also reported to be increasing [5].
The reasons behind this trend have not been
studied in a scientific way. The authors be-
lieve this could be a result of increased life
expectancy  and  increased  prevalence  of
other risk factors described below.
The exact underlying cause of AAA is
uncertain. The key event is destruction of
elastin in the aortic wall that creates abnor-
mal stress as a result of the blood pressure
within the lumen [6].The strongest risk fac-
tor associated with AAA is cigarette smok-
ing  [3,7].  Age  is  also  considered  a
significant risk factor with a dramatic in-
crease in prevalence in patients older than
60 [1,4]. Other significant risk factors in-
clude male sex, hypertension, and Caucasian
race [4,7]. Atherosclerosis has been consid-
ered the etiology of an overwhelming ma-
jority of AAAs [8]. It is interesting to note
that several risk factors associated with AAA
also predict atherosclerosis. Some examples
are  cigarette  smoking,  hypertension,  and
high serum cholesterol. Hence, AAA and
atherosclerotic disease usually coexist. It is
unclear  whether  atherosclerotic  disease
causes  AAA  or  vice-versa  [9].  Genetic
causes for AAA have also been suggested
[10]. Infectious agents, cystic medial necro-
sis, and Marfans syndrome are other rare
causes of AAA. 
A mycotic aneurysm is destruction of
the vessel wall leading to dilatation of an ar-
tery caused by infection due to a microor-
ganism. Mycotic aneurysms are uncommon.
In  one  study,  only  0.9  percent  of  all
aneurysms were found to be mycotic [11].
The  infectious  agent  is  generally  a  bac-
terium, although other microorganisms are
also implicated in rare cases [12]. GBS caus-
ing a mycotic aneurysm is extremely rare,
and so far, only five cases have been re-
ported [13-17]. Among these cases, three
were associated with AAA [13], and one
each was associated with ascending aorta
[15] and common femoral artery [14]. It is
interesting to note that the incidence of my-
cotic AAA has increased in the post antibi-
otic  era  [18],  while  the  incidence  of
peripheral mycotic aneurysms has decreased
[19]. The reasons behind this shift are not
clear.
GBS is a pathogen that colonizes the
gastrointestinal and genital tracts in humans
[20]. It is a gram positive coccus. In preg-
nant and postpartum women, GBS is known
to cause urinary and genital tract infections,
postpartum endometritis, puerperal sepsis,
and bacteremia [21,22]. GBS is also an im-
portant causative agent of illnesses in infants
(respiratory tract infections and septicemia)
as a result of vertical transmission [23]. A
significant proportion of GBS cases have
been reported in elderly populations such as
non-pregnant  women  older  than  65  and
nursing home residents [17]. However, it is
exceedingly rare for GBS to cause an AAA. 
cASe report
A  75-year-old  Caucasian  male  pre-
sented with 2-day history of left leg swelling
and discomfort. Review of systems was pos-
itive for mild back pain, fever, night sweats,
and weight loss. Past medical history was
significant for ischemic heart disease, hy-
pertension, hyperlipidemia, and chronic ob-
structive  lung  disease.  He  also  had  a
60-packs-a-year cigarette smoking history.
There was no family history of AAA. One
month  ago  prior  to  presentation,  he  was
treated for suspected bronchitis/exacerbation
of chronic obstructive lung disease with 1
week of intravenous moxifloxacin (400 mg
daily) as an inpatient and 1 more week of
oral moxifloxacin (400 mg daily) as an out-
patient. Physical examination was signifi-
cant for 4+ pitting edema and tenderness in
the left lower extremity. The patient’s labo-
ratory workup was remarkable for elevated
C-reactive protein (CRP) 23.630 mg/dl (nor-
mal value <0.8 mg/dl); elevated erythrocyte
sedimentation rate (ESR) of >100mm in the
first hour (normal range 0-20 mm/h); leuco-
cytosis, white blood cell count 14,000/cu
mm (normal range, 3,000-10,000/cu mm);
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45-70 percent). Doppler ultrasound of the
lower extremities demonstrated extensive
deep venous thrombosis (DVT) involving
the left popliteal vein, left common femoral
vein, and extending into the left external
iliac vein. Anticoagulation was started with
low-molecular weight heparin, and further
imaging was done at this time as extensive
DVT raised the suspicion of malignancy.
Contrast  enhanced  chest,  abdomen,  and
pelvis computed tomography (CT) showed
an  infrarenal  irregular  abdominal  aortic
aneurysm (5.7 cm x 4.0 cm x 5.1 cm) with a
contained rupture (Figures 1 and 2). A my-
cotic aneurysm was suspected with clinical
picture of fever, low back pain, leucocyto-
sis, and the irregular CT appearance of the
aneurysm.  Intravenous  Vancomycin  1gm
every 12 hours and intravenous Piperacillin-
Tazobactam  3.375gm  every  6  hours  was
started empirically. 
Emergency laparotomy was performed
and confirmed the presence of a contained
aneurysmal  leak. The  aneurysm  was  ex-
cised, and circulation was re-established by
collagen-impregnated  Dacron  graft  pre-
soaked in Rifampin. 
Transesophageal echocardiogram did
not show any valvular vegetations. Histo-
logical examination of excised wall showed
heavy infiltration with Gram-positive cocci
within the arterial wall (Figures 3 and 4).
The culture of the aneurysmal contents was
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Figure 1. Axial contrast
enhanced CT of the ab-
domen demonstrating an
infrarenal abdominal
aortic aneurysm (arrow-
heads). The large black
arrow shows a small
area of low attenuation
in the anterior right
psoas muscle that was
confirmed to be a con-
tained rupture during
surgery. 
Figure 2. Re-
constructed CT
image in the
coronal plane
shows an irregu-
lar infrarenal ab-
dominal aortic
aneurysm (ar-
rowheads).positive for GBS, consistent with the diag-
nosis of mycotic AAA. Further laboratory
evaluation showed that the causative GBS
in this case was sensitive to penicillin G:
minimum inhibitory concentration (MIC)
<0.03mg/L. After culture results, patient’s
antibiotics were replaced with intravenous
gentamicin (60 mg every 12 hours for 2
weeks)  and  intravenous  ceftriaxone  (2  g
once daily for 2 weeks). He developed a
granulocytopenic reaction that was attrib-
uted to ceftriaxone, and antibiotic treatment
was changed to intravenous moxifloxacin
(400 mg once daily, MIC: <1mg/L). After 6
weeks  of  parenteral  antibiotics,
suppressive long-term oral antibi-
otic  therapy  with  moxifloacin
(400 mg orally daily) was started.
Blood cultures taken at the time of
admission and during hospitaliza-
tion were all negative. Magnetic
resonance imaging of the lumbar
spine did not show any evidence
of diskitis and/or osteomyelitis.  
Our  patient  has  remained
asymptomatic  for  more  than  1
year. There are no signs of relapse
of  infection,  and  inflammatory
markers are within normal limits
(CRP: 0.3 mg/dl, ESR 16mm/hr).
diScuSSion
Sir  William  Osler  first  de-
scribed the term mycotic aneurysm
in a landmark lecture to the Royal
College  of  Physicians  in  1885
[24]. He described the vegetations
in the internal surface of the aorta
as  “fresh  fungus”  and  hence
coined  the  term  “mycotic.”  Sir
Osler postulated that embolization
of organisms from bacterial endo-
carditis led to septic degeneration
of the vessel wall, leading to for-
mation  of  an  aneurysm.  Even
though  bacteria  are  causative
agents in the majority of cases,
eventually  the  term  “mycotic
aneurysm” became synonymous to
describe all types of infected aneurysm. As
it is a misnomer, it has been suggested that
“infected aneurysm” is a better term [25].The
mechanism is believed to be microbial arter-
titis as result of invasion of bacteria in a pre-
viously normal or damaged arterial wall [26].
Mycotic aneurysms can occur almost any-
where in the body. Abdominal aorta was
found be the second most common site (31
percent), after femoral artery (38 percent) in
one study [26].
There are several mechanisms that may
describe pathogenesis of a mycotic aneurysm.
In the pre-antibiotic era, septic emboli origi-
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Figure 3. Abdominal aortic aneurysm ― thrombus,
microscopically (10x) shows mural thrombus consist-
ing layers of red blood cells (between the block ar-
rows) alternated with fibrin admixed with platelets
(shown by brackets).  
Figure 4. Abdominal aortic aneurysm ― bacteria, tis-
sue gram stain of thrombus (100x, oil immersion)
shows gram positive cocci in pairs or chains consis-
tent with Group B Streptococci.nating from bacterial endocarditis was most
common [27]. In our case, bacterial endo-
carditis was ruled out with repeated negative
blood cultures at the time of admission and
during hospitalization. No valvular vegeta-
tions were seen on transesophageal echocar-
diogram. Other causes of bacteremia such as
recent dental work were also not present.
Skin and soft tissue infections due to GBS
could lead to bacteremia and remote hemato-
geneous seeding. No such infections were
noted in the index case. Our patient does have
a history of suspected bronchitis/exacerbation
of chronic obstructive lung disease about a
month prior to presentation. However, blood
cultures were not taken during that admis-
sion. Any kind of arterial trauma, iatrogenic
or self induced, may predispose the arterial
wall to infection [28]. However, in our case,
there is no history of injection drug use or an
intervention such as percutaneous arterial
puncture. Direct contiguous spread of local
infection also may cause microbial invasion
of the vessel wall [26,29]. In the index case,
cross-sectional  imaging  with  CT  did  not
demonstrate any abdominal focus of infec-
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table 1. review of previously published case reports of GBS-associated AAA.
Age/Gender
Presenting 
complaints
Suspected source
of infection
Pyrexia (+/−)
Blood cultures   
Vegetations on
Echocardiography 
Surgical treatment
Graft material
Antibiotics and 
duration
outcome
Blackett et al.
1989
61/Male
Severe low
back pain
osteomyelitis
of L2/L3
+
Negative 
Not seen
Excision and
grafting
Knitted Dacron
Benzylpenicillin
(2 wk) and
erythromycin (8
wk)
Cured
Andreasen et
al. 2001
40/Male
Acute 
abdominal
pain
Unknown
+
Negative
Not seen
Excision and
Iliaco-femoral
bypass graft
Unknown
Cefuroxime
(4 wk)
Cured
Chandrikakumari
et al. 2007
69/Male
Abdominal pain
radiating to
flanks
Infected 
epidermal 
inclusion cyst
-
Not done
Not seen
Excision and
grafting
Allograft
Benzylpenicillin
(2 wk), ceftriax-
one (4 wk), and
moxifloxacin
(18 wk)
Cured
Present Case 
74/Male
Back pain, low
grade fevers,
leg swelling
Unknown
+
Negative
Not seen
In situ 
reconstruction
with rifampin-
soaked graft
Dacron
Gentamycin (2
wk), ceftriax-
one* (2 wk)
followed by
moxifloaxin (4
weeks); Life-
long suppres-
sion (oral
moxifloxacin)
Cured
*Ceftriaxone was replaced with Moxifloxacin due to drug reaction.tion. There was a concern for diskitis and/or
osteomyelitis that could have spread locally
to involve the aorta. A magnetic resonance
scan of the lumbar spine did not show any ev-
idence of diskitis and/or osteomyelitis, ruling
this out as a cause of mycotic AAA. Diabetes,
alcoholism, and malignancy that cause im-
paired immunity also have been identified as
risk factors [30]. In our case, none of these
risk factors were present. The source of in-
fection is not found in most cases of mycotic
aneurysm [18,25], and the same is true in our
case.  
The most common organisms causing
mycotic aneurysms were Streptococcus pyo-
genes, S. pneumoniae, and staphylococci in
the pre-antibiotic era [27]. With the wide
availability of antibiotics, a shift has been
noted in the microbiology of these infec-
tions. In the post antibiotic era, the most
common causative organisms are the Sal-
monella species (up to 50 percent) and the
Staphylococcus aureus [19]. Untreated Sal-
monella gastroenteritis could lead to inva-
sive infection and involvement of the arterial
wall [31] and has a predisposition for early
rupture [32]. Other organisms such as Liste-
ria monocytogenes, Bacteroides fragilis, and
Campylobacter  fetus have  also  been  re-
ported [12].
Antibiotics
For treatment purposes, we followed
the recommendations for antimicrobial man-
agement of infective endocarditis, as my-
cotic AAA essentially is bacterial infection
of the abdominal aortic wall [33]. It is rec-
ommended that patients receive 6 weeks of
antimicrobial therapy with penicillin, cefa-
zolin, or ceftriaxone. Some studies have rec-
ommended the addition of gentamicin to
penicillin or a cephalosporin for at least the
first 2 weeks of the 6-week course of an-
timicrobial therapy [34]. As per current rec-
ommendations, our patient received a total
of 6 weeks of intravenous antibiotic treat-
ment, detailed above in the case report sec-
tion  [33].  There  are  no  definitive
recommendations for the duration of the
postoperative antibiotic therapy in published
literature. In the previously published case
reports  of  infected  abdominal  aortic
aneurysms, the maximum duration of treat-
ment was 18 weeks and all cases were cured
[13,16,17] (Table 1). It has been suggested
that it may be desirable to use long-term oral
antibiotic suppression treatment in patients
at high risk of recurrence of infection, such
as those with interposed vascular grafts in
infected areas [33]. A small animal experi-
mental study also supported long-term an-
tibiotic suppression and showed that total
“graft sterility” cannot be expected in the
case of an overwhelming bacterial challenge
[35]. 
The fact that the patient received mox-
ifloxacin prior to this admission for sus-
pected bronchitis could have led to a better
outcome.  Multiple  recent  studies  have
shown that GBS is still highly sensitive to
moxifloxacin [36]. Good outcome was also
reported with moxifloxacin in another pub-
lished case report [17].
Surgery
Surgical repair is the first-line treatment
for an infected aortic aneurysm and may be
done by a synthetic extra anatomic bypass
or in situ reconstruction with a graft. There
is limited evidence-based information that
favors any one particular surgical approach
over the other [37]. Earlier studies showed
lower risk of infection with autologous vein
grafts [38,39]; however, in situ reconstruc-
tion, which was employed in our case, has
been the favored technique in recent studies
[40]. Experimental studies in small animals
have shown decreased adherence of bacte-
ria to the graft and decreased incidence of
graft infection if the grafts were soaked in
rifampin  solution  prior  to  implantation
[41,42]. The collagen-impregnated Dacron
graft used for in situ reconstruction in this
case was pre-soaked in rifampin solution. 
concLuSion
Although  mycotic  AAA  is  rare,  it
should be considered in patients with fever
of unknown origin, vague abdominal and
back  pain,  and  constitutional  symptoms.
Mycotic AAA with GBS is extremely rare in
102 Thawait et al: Abdominal aorta aneurysm associated with Group B Streptococcusthe post-antibiotic era. There is a paucity of
evidence-based human studies regarding op-
timal surgical and antibiotic management. 
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